Studies | RAd-p53 | RT | CT | Stages | Jadad |
---|---|---|---|---|---|
Qin et al. (2012) | 1 × 1012 VP 1 time/week/6–7 weeks | Nasopharynx: 70–76 Gy/35–38f Neck: 66–70 Gy | Carboplatin: 500 mg/m2 Fluorouracil: 2000 mg/m2 | III–IV | 2 |
Lan et al. (2011) | 1 × 1012 VP 1 time/week/6–8 weeks | Nasopharynx: 70–76 Gy/35f Neck: 60–70 Gy | Carboplatin: 500 mg/m2 5-Fluorouracil: 2000 mg/m2 | III–IV | 2 |
Wang et al. (2010) | 1 × 1012 VP Saline dilution 2–4 ml | Nasopharynx: 70 Gy/35f Neck: 70 Gy/35f | – | III–IV | 2 |
Li (2012) | 1 × 1012 VP – | Nasopharynx: 70–76 Gy/7–8 weeks Neck: 60–70 Gy | Carboplatin: 300–500 mg/m2 5-Fluorouracil: 300–500 mg/m2 | III–IV | 2 |
Chen et al. (2003) | 1 × 1012 VP 1 time/week/8 weeks | Nasopharynx: 70–76 Gy/7–8 weeks Neck: 60–70 Gy/7–8 weeks | – | II–IV | 2 |
Si et al. (2009) | 1 × 1012 VP 1 time/week/6–8 weeks | Nasopharynx: 70–76 Gy/7–8 weeks Neck: 36 Gy/4 weeks 60–70 Gy/3–4 weeks | Carboplatin: 300–500 mg/m2 5-Fluorouracil: 300–500 mg/m2 | III–IV | 3 |
Wang et al. (2012) | 1 × 1012 VP 1 time/week/9–10 weeks | Nasopharynx: 66–70 Gy/35f Neck: 66–70 Gy/35f | – | I–III | 2 |
Zhang et al. (2006) | 1 × 1012 VP 1 time/week/8 weeks | Nasopharynx: 70 Gy/35f Neck: 70 Gy/35f | – | Unclear | 3 |
Zhang et al. (2011) | 2 × 1012 VP 1 time/week/6 weeks | 68–76 Gy to 60–70 Gy/6 weeks | Cisplatin: 75 mg/m2 Paclitaxel: 75 mg/m2 | III–IV | 3 |
Pan et al. (2009) | 1 × 1012 VP 1time/week/8 weeks | Nasopharynx: 70 Gy/35f Neck: 70 Gy/35f | – | II–IV | 3 |
Lan et al. (2012) | 1 × 1012 VP 1 time/3 days/6–8 times | 70–76 Gy/35–38f | Cisplatin: 300 mg/m2 5-Fluorouracil: 2000 mg/m2 | Unclear | 2 |
Zhang et al. (2007) | 1 × 1012 VP 1 time/1 week/8 times | Nasopharynx: 70 Gy/35f Neck: 70 Gy/35f | – | Unclear | 3 |